✦ LIBER ✦

Pilot neoadjuvant trial in HER2 positive breast cancer with combination ofnab-paclitaxel and lapatinib

✍ Scribed by Virginia G. Kaklamani; Kalliopi Siziopikou; Denise Scholtens; Mario Lacouture; Jennifer Gordon; Regina Uthe; Caitlin Meservey; Nora Hansen; Seema A. Khan; Jacqueline S. Jeruss; Kevin Bethke; Mary Cianfrocca; Steven Rosen; Jamie Von Roenn; Jeffrey Wayne; Vamsi Parimi; Borko Jovanovic; William Gradishar

Book ID: 113062252
Publisher: Springer US
Year: 2011
Tongue: English
Weight: 289 KB
Volume: 132
Category: Article
ISSN: 0167-6806
DOI: 10.1007/s10549-011-1411-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Targeted therapies: Combined lapatinib a

Targeted therapies: Combined lapatinib and paclitaxel in HER2-positive breast cancer

✍ Castañeda, Carlos A.; Gomez, Henry L. 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 88 KB

A phase Ib study of preoperative lapatin

A phase Ib study of preoperative lapatinib, paclitaxel, and gemcitabine combination therapy in women with HER2 positive early breast cancer

✍ In Hae Park, Keun Seok Lee, Han-Sung Kang, Seok Won Kim, Seeyoun Lee, So-Youn Ju 📂 Article 📅 2011 🏛 Springer US 🌐 English ⚖ 158 KB

Phase III trial of nonpegylated liposoma

Phase III trial of nonpegylated liposomal doxorubicin in combination with trastuzumab and paclitaxel in HER2-positive metastatic breast cancer

✍ Baselga, J.; Manikhas, A.; Cortes, J.; Llombart, A.; Roman, L.; Semiglazov, V. F 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 273 KB

Combination neratinib (HKI-272) and pacl

Combination neratinib (HKI-272) and paclitaxel therapy in patients with HER2-positive metastatic breast cancer

✍ Chow, L W-C; Xu, B; Gupta, S; Freyman, A; Zhao, Y; Abbas, R; Vo Van, M-L; Bondar 📂 Article 📅 2013 🏛 Nature Publishing Group 🌐 English ⚖ 246 KB

Trastuzumab-based neoadjuvant therapy in

Trastuzumab-based neoadjuvant therapy in patients with HER2-positive breast cancer

✍ Helena R. Chang 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 348 KB 👁 2 views

5073 Lapatax: Safety profile of neoadjuv

5073 Lapatax: Safety profile of neoadjuvant lapatinib combined with docetaxel in Her 2/neu overexpressing breast cancer – EORTC protocol 10054

✍ H. Bonnefoi; K. Zaman; M. Nobaher; E. Brain; J.Y. Pierga; K.M. Koch; J. Bartlett 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 49 KB